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inhibitors were associated with increased survival regardless of LVSF. the relationship 
was lees pronounced in patients with preserved LVSF (p<O.Ol). 
Conclusions: Although older patients hospitalized with heart failure and normal LVSF 
have belter survival than those with impaired LVSF, mortality rates are high in all groups. 
ACE-inhibitors attenuate the relationship between reduced LVSF and Increased morial- 
ity. 
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Lefi Atrial Volume Is More Strongly Associated With 
Prevalent Congestive Heart Failure and Predictive of 
Incident Congestive Heart Failure in the Elderly Than 
Doppler Mitral Inflow Velocities or Deceleration Time 
John S. Gotrdiener. Dalane W. Kitzman, Gerard P. Aurigemma, Alice M. Arnold, Cheryl 
S. Egher, Karen M. Fowle, Jeffrey C. Hill, St. Francis Hospital, Roslyn, NY, NHLBI, 
Bethesda, MD 
In elderly pts, diastolic dysfunction presumably accounts for the large proportion (approx. 
50% of our cohort) of heart failure (HF) with normal systolic function (diastolic HF). Both 
LA size and Doppler parameters of L V diastolic filling are commonly abnormal in HF.We 
evaluated the relative contribution of LA volume (vol)(ZD echo ellipsoid model), mitral 
inflow deceleration (DECEL) time, early (Epk)and late (Apk) peak velocities of mitral 
inflow, as well as LV ejection fraction (EF) for association with prevalent HF and for pre- 
diction of incident HF. Methods: Within the Cardiovascular Health Study. a community- 
based study of cardiac risk in individuals > age 85, we did a case control study of 636 
participants (ppts) (av age 79+/-6 yrs, range 68-99) of whom 121 had HF (prevalent HF) 
at the time of echo evaluation, 179 developed HP within 5 yrs of the baseline echo (inci- 
dent HF), and 336 were age and gender matched controls. Odds ratios were calculated 
in a multivariate model adjusting for age, sex, prevalent and subclinical CV disease, dia- 
betes, hypeltension, height, weight, and atrial fibrillation. Results: see table. Conclusion: 
LAvol is associated with prevalent CHF and is predictive of incident CHF independently 
of LV systolic function, and independently of mitral inflow velocities, deceleration time, as 
well as clinical covariates. While Apk velocity has associative and predictive value, Epk 
and DECEL time do not. 
Odds Ratios (95% C.I.) 
CHF LAvol Decel time E velocity A velocity &F 
Prevalent 3.7(2.3-6.0)’ .9(.6-1.4) 1.1(.7-1.7) 1.5(1 .O-2.3) 7(3-l 6) 
* 
Incident 2.7(1.9-3.8) 1.1(.9-1.4) l.l(.E-1.4) 1.3(1.0-l .8) 2.4(1.2-4.8) 
$ $ 
‘p,<.OOl ,$pc.O4. Odds ratios per parameter S.D. except for EF which was expressed 
as a categorical variable -decreased vs normal. 
1038-70 Diastolic Dysfunction: An Important Predictor of 
Survival in Patients With Preserved Systolic Function 
Richard V. Milani. Carl J. Lavie, Mandeep R. Mehra, Josh Kurtz, Hector 0. Ventura, 
Ochsner Clinic Foundation, New Orleans, LA 
Background: Diastolic dysfunction (DD) carries a poor prognosis when identified in 
patients (pts) with reduced systolic function (SF). However, little is known regarding out- 
come in pts with diastolic filling abnormalities and preserved SF. 
Methods: We assessed diastolic filling and mortality in 7,216 pts (2,885 pts < 50 years, 
2,536 pts 50-70 years, and 1,795 pts > 70 years) with preserved SF (EF >/= 50%) 
referred for echo (mean follow-up of 3.1 years). DD was categorized as either relaxation 
abnormality, pseudonormalization, or restrictive filling panem by standard Doppler 
echocardiographic criteria. 
ResuI1s: DD was extremely prevalent in all age groups, occurring in 40%, 44%. and 70% 
of pts under age 50, 50-70, and > 70 years, respectively. Although EF and BMI were sim- 
tlar in pts with and without DD for all age groups. marked increases in mortality were 
observed in pts with DD (2.fold increased mortality I” pts < 70 years, and 38% increased 
mortality in pts > 70 years; see figure). All categories of DD had similar increases in rnor- 
tality. 
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Conclusions: DD is highly prevalent in pts with preserved SF, increases with age, and is 
associated with a marked increase in mortality. 
1038-71 Heart Failure and/or Left Ventricular Systolic 
Dysfunction Complicating Myocardial Infarction Is 
Common and Accounts for the Majority of In-Hospital 
Myocardial Infarction Mortality: Results of the VALIANT 
Registry 
Eric J. Velazauez. W. Douglas Weaver, Paul W. Armstrong, Rakhi Kilaru, Rafael Diaz. 
Harvey D. White, Wiek H. van Gilst, Jiri Spat, Christopher M. O’Connor, Gary S. Francis, 
Helmut Drexler, Viatcheslav Y. Mareev, Aldo P. Maggioni, Jeffrey D. Leimberger, Marlin 
Myers, Marc Henis, Robert M. Califf, Duke Clinical Research Institute, Durham, NC 
Background: We designed a registry as an adjunct to the VALsartan In Acute myocar- 
dial iNfarcTion (VALIANT) trial to define the incidence of heart failure (HF) and/or left 
ventricular systolic dysfunction (LVSD) prior to discharge following myocardial infarction 
(MI) and lo determine its incremental mortality risk. 
Methods/Results: The VALIANT registry enrolled 5,592 consecutive Ml pts (85 hospi- 
tals. 9 countries) from 200&2001 during prearranged screening periods, with follow-up 
until in-hospital death or discharge. Overall in-hospital modality was 6.8%. Of the MI pts 
entered in cur registry. 42% (n = 2,352) had HF and/or LVSD defined by either clinical or 
radiographic signs of HF and/or LVSD imaging evidence. Selected outcome differences 
are presented (Table). A multivariable logistic model for in-hospital mortality was devel- 
oped (global x 2 = 479.29; C-Index = 0.811). Adjusting for baseline risk, HF and/or LVSD 
was associated with a hazard ratio of 4 39 (95% Cl 3.33 - 5.84). Among HF and/or LVSD 
pts, 34.2% received angiotensin-converting enzyme (ACE) inhibitors and 58.0% beta 
blockers within 24 hours after presentation; 31.4% underwent percutaneous and 11 .O% 
surgical revascularization before discharge. 
Conclusions HF and/or LVSD cccurs in a sizeable minority of contemporary Ml pts and 
accounts for the vast majority of deaths. ldentlfying these pts during the ccurse of Ml 
could trigger mere intensive medical therapy. including revascularization, than that 
observed in the registry. 
Outcomes by In-Hospital HF and/or LVSD Development 
Atrial fibrillation. % 
Stroke. % 
Recurrent MI, % 
Mortality, % 
Mean length of stay, 
days 
HF and/or LVSD (n = No HF and/or LVSD (n = 
2,352) 3,240) 
16.3 7.1 
2.2 0.9 
2.5 1.4 
12.9 2.2 (p < 0.001) 
12.0 7.6 
1038-72 Are NT-Pro Brain Natriuretic Peptides Related to 
Systolic and Diastolic Left Ventricular Function at 
Baseline and During Antihypertensive Treatment? The 
LIFE Study 
Kristian Wachtell. Michael H. Olsen, Christian Tuxen. Lia E. Bang, Christian Hall, Per R. 
Hildebrandt. Hans Ibsen. Jens E. Rokkedal, Richard 6. Devereux, Glostrup University 
Hospital, Glostrup, Denmark, The Weill Medical College of Cornell University, New York, 
NY 
Background: NT-pro-brain natriuretic peptide (NT-pro-BNP) has been shown to predict 
systolic left ventricular (LV) function in patients with congestive heart failure (CHF). Fur- 
thermore, LV function is related lo LV mass and wall stress. It remains unclear whether 
NT-pro-BNP IS related to systolic or diastolic LV function in hypertensive patients without 
CHF and whether this relation is independent of wall stress and LV mass. 
Methods: Clinical, laboratory and echocardiographic variables were assessed in 184 
hypertensive patients with ECG LV hypertrophy. aged 55-80 (mean 66*7 years) at base- 
line after 2 weeks’ placebo and after one year of systematic antihypertensive treatment. 
NT-pro-BNP was measured by immunoassay (Elecsys proBNP). 
Results: NT-pro-BNP at baseline was negatively related to endocardial (EFS. r=-0.251) 
and midwall fractional shortening (MWS, r=-0.245. both p=O.OOl). With adjustment for 
circumferential end-systolic stress, MWS (p=-0.155, ~~0.05) but not EFS (@=-0.028, NS) 
remained related to NT-pro-BNP. However, when taking LV mass wall stress into 
account there was only a trend towards a relation between NT-pro-BNP and MWS (p=- 
